180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer

Core Viewpoint - 180 Life Sciences Corp. has appointed Omar Jimenez as the new Chief Financial Officer, effective September 30, 2024, to enhance its financial strategy during a period of growth and innovation in the pharmaceutical and biotechnology sectors [1]. Group 1: Leadership Changes - Omar Jimenez, previously a director at 180 Life Sciences, will take on the role of CFO, bringing extensive financial expertise and a forward-thinking approach to the executive team [1]. - The company expresses gratitude to former CFO Ozan Pamir for his contributions and wishes him well in future endeavors [2]. Group 2: Company Overview - 180 Life Sciences Corp. is a clinical stage biotechnology company focused on developing therapeutics for unmet medical needs, particularly in chronic pain, inflammation, and fibrosis, utilizing innovative research and combination therapy where applicable [3].